home / stock / htgm / htgm news


HTGM News and Press, HTG Molecular Diagnostics Inc. From 09/21/21

Stock Information

Company Name: HTG Molecular Diagnostics Inc.
Stock Symbol: HTGM
Market: NASDAQ
Website: htgmolecular.com

Menu

HTGM HTGM Quote HTGM Short HTGM News HTGM Articles HTGM Message Board
Get HTGM Alerts

News, Short Squeeze, Breakout and More Instantly...

HTGM - HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

TUCSON, Ariz., Sept. 21, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will present in a fireside chat in Cantor Fitzgerald’s Virtual G...

HTGM - HTG Molecular Diagnostics to Present at H.C. Wainwright's 23rd Annual Global Investment Conference

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investm...

HTGM - HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2021 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) Q2 2021 Earnings Conference Call August 12, 2021 16:30 ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Rick Miller - Cantor Fitzgerald...

HTGM - HTG Molecular Diagnostics Reports Second Quarter 2021 Results

TUCSON, Ariz., Aug. 12, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2021. Recent Business Highlights ...

HTGM - HTG's New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe

HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology Intended to serve as one of the technological cornerstones for the recently announced HTG Therapeutics Business Unit A third white paper highlighting the ...

HTGM - HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12

TUCSON, Ariz., Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2021 after the market ...

HTGM - HTG Forms New Drug Discovery Business Unit

TUCSON, Ariz., July 20, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the creation of a new business unit, HTG Therapeutics. HTG plans to use this new drug discovery ...

HTGM - HTG Receives First Commercial Orders for its Planned HTG Transcriptome Panel and Announces the Signing of Two European Early Adopter Program Agreements

TUCSON, Ariz., June 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome Panel and has sign...

HTGM - HTG Molecular completes product design lock for planned transcriptome panel

HTG Molecular Diagnostics (HTGM) has completed product design lock for the HTG Transcriptome Panel and announced three Early Adopter Program ((EAP)) collaborators.Shares up more than 8% premarket.The panel, expected to be called the HTG Transcriptome Panel, will measure about 2...

HTGM - HTG Completes Product Design Lock for its Planned Transcriptome Panel and Announces the Signing of the Three Early Adopter Program Collaboration Agreements

TUCSON, Ariz., June 14, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has completed product design lock for the HTG Transcriptome Panel and announced three Early A...

Previous 10 Next 10